Effect of mestranol and superlutin in mobilization of calcium from bone in artificial hyperparathyroidism.
D000085:Acetates / Q000494:pharmacology; D000818:Animals; D001862:Bone Resorption / Q000187:drug effects; D001842:Bone and Bones / Q000378:metabolism*; D002118:Calcium / Q000097:blood / Q000378:metabolism*; D005260:Female; D006961:Hyperparathyroidism / Q000378:metabolism*; D008274:Magnesium / Q000097:blood; D008656:Mestranol / Q000494:pharmacology*; D010281:Parathyroid Hormone / Q000494:pharmacology; D010710:Phosphates / Q000097:blood; D011374:Progesterone / Q000031:analogs & derivatives* / Q000494:pharmacology; D045167:Progesterone Congeners / Q000494:pharmacology*; D051381:Rats
D000085:Acetates; D010281:Parathyroid Hormone; D010710:Phosphates; D045167:Progesterone Congeners; D011374:Progesterone; D008656:Mestranol; D008274:Magnesium; D002118:Calcium